Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury.

Juengst SB, Kumar RG, Failla MD, Goyal A, Wagner AK.

J Head Trauma Rehabil. 2015 May-Jun;30(3):207-18. doi: 10.1097/HTR.0000000000000031.

PMID:
24590155
2.

Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.

Santarsieri M, Kumar RG, Kochanek PM, Berga S, Wagner AK.

Brain Behav Immun. 2015 Mar;45:15-27. doi: 10.1016/j.bbi.2014.09.003. Epub 2014 Sep 16.

3.

Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury.

Kumar RG, Boles JA, Wagner AK.

J Head Trauma Rehabil. 2015 Nov-Dec;30(6):369-81. doi: 10.1097/HTR.0000000000000067.

PMID:
24901329
4.

Inflammation biomarkers in vaginal fluid and preterm delivery.

Taylor BD, Holzman CB, Fichorova RN, Tian Y, Jones NM, Fu W, Senagore PK.

Hum Reprod. 2013 Apr;28(4):942-52. doi: 10.1093/humrep/det019. Epub 2013 Feb 15.

5.

In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury.

Frugier T, Morganti-Kossmann MC, O'Reilly D, McLean CA.

J Neurotrauma. 2010 Mar;27(3):497-507. doi: 10.1089/neu.2009.1120.

PMID:
20030565
6.

Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome.

Kumar RG, Diamond ML, Boles JA, Berger RP, Tisherman SA, Kochanek PM, Wagner AK.

Brain Behav Immun. 2015 Mar;45:253-62. doi: 10.1016/j.bbi.2014.12.021. Epub 2014 Dec 31.

PMID:
25555531
7.

Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.

Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC.

J Neuroimmunol. 2002 Jan;122(1-2):167-74.

PMID:
11777556
8.

Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury.

Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, Mouri T, Tajima G, Kajino K, Nakae H, Tanaka H, Shimazu T, Sugimoto H.

Shock. 2005 May;23(5):406-10.

PMID:
15834305
9.

Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury.

Kumar RG, Rubin JE, Berger RP, Kochanek PM, Wagner AK.

Brain Behav Immun. 2016 Mar;53:183-93. doi: 10.1016/j.bbi.2015.12.008. Epub 2015 Dec 17.

PMID:
26705843
10.

[Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].

Scudla V, Budíková M, Bacovský J, Opíchalová D, Farbiaková V.

Cas Lek Cesk. 2000 Jul 5;139(13):401-6. Slovak.

PMID:
10971970
11.

Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients.

Wirtz PH, Redwine LS, Linke S, Hong S, Rutledge T, Greenberg BH, Mills PJ.

Brain Behav Immun. 2010 Mar;24(3):366-9. doi: 10.1016/j.bbi.2009.02.004. Epub 2009 Feb 13.

PMID:
19217936
12.

Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Rhind SG, Crnko NT, Baker AJ, Morrison LJ, Shek PN, Scarpelini S, Rizoli SB.

J Neuroinflammation. 2010 Jan 18;7:5. doi: 10.1186/1742-2094-7-5.

13.

Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients.

Cheng CH, Chen YS, Shu KH, Chang HR, Chou MC.

Nephrology (Carlton). 2012 Nov;17(8):718-24. doi: 10.1111/j.1440-1797.2012.01654.x.

PMID:
22905988
15.

sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells.

Otto VI, Heinzel-Pleines UE, Gloor SM, Trentz O, Kossmann T, Morganti-Kossmann MC.

J Neurosci Res. 2000 Jun 15;60(6):733-42.

PMID:
10861785
16.

Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.

Derosa G, Cicero AF, Fogari E, D'Angelo A, Bonaventura A, Romano D, Maffioli P.

J Clin Lipidol. 2012 Nov-Dec;6(6):553-64. doi: 10.1016/j.jacl.2012.02.010. Epub 2012 Feb 27.

PMID:
23312051
17.

Exploratory associations with tumor necrosis factor-α, disinhibition and suicidal endorsement after traumatic brain injury.

Juengst SB, Kumar RG, Arenth PM, Wagner AK.

Brain Behav Immun. 2014 Oct;41:134-43. doi: 10.1016/j.bbi.2014.05.020. Epub 2014 Jun 11.

PMID:
24928066
18.

IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.

Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T.

J Neuroimmunol. 1999 Nov 15;101(2):211-21.

PMID:
10580806
19.
20.

Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, Barrera P, van den Berg WB.

Arthritis Rheum. 2003 Feb;48(2):339-47.

Items per page

Supplemental Content

Write to the Help Desk